SanegeneBio taps Orbit Discovery to generate targeting peptides for RNA therapies
SanegeneBio has formed a service agreement with Orbit Discovery to support tissue-specific delivery of a wide range of RNA therapeutics.
SanegeneBio has formed a service agreement with Orbit Discovery to support tissue-specific delivery of a wide range of RNA therapeutics.
A study performed by Florence Healthcare showed that clinical software adoption is expected to rise dramatically during 2023.
The Alachua, Florida location comprises laboratory and office space for biotech businesses.
Eurofins announces that it relocated and expanded its API development laboratories by moving to a new space in Ontario, Canada.
Bayer signs a collaboration agreement that applies Google Cloud’s computing power to drug discovery.
Proteros biostructures has landed private equity funding, positioning the German drug discovery service provider to expand in the US.
Celadon Pharmaceuticals Plc has become the first to clear the regulations to make medical cannabis in the UK.